Skip to main content

Table 1 Basic clinical and serum biochemistry variables and their association with circulatory IL-17 concentrations

From: Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

Item

Values

Beta

Confidence interval

P

Coefficient

Low

High

Patient #

404

    

IL-17 (ng/ml)

5.57 ± 18.74

    

Age (years)

59.37 ± 10.94

91.4

 − 76.4

259.2

0.285

Gender-Male

249 (61.6%)

1814.3

 − 1956.2

5584.8

0.345

HBV positivity

237 (58.7%)

 − 1293.9

 − 5019.2

2431.4

0.495

HCV positivity

128 (31.7%)

2587.2

 − 1350.0

6524.4

0.197

AST (IU/L)

45.38 ± 40.61

 − 2.9

 − 48.2

42.5

0.900

ALT (IU/L)

39.76 ± 45.48

 − 13.7

 − 54.2

26.8

0.506

Bilirubin (mg/dL)

1.43 ± 5.47

 − 7.4

 − 344.1

329.3

0.965

AFP (ng/ml)

8.84 ± 28.99

21.6

 − 41.9

85.0

0.505

Albumin (g/dL)

3.61 ± 0.44

1222.5

 − 3006.3

5451.2

0.570

Total protein (g/dL)

7.21 ± 0.67

 − 455.5

 − 3188.5

2277.5

0.743

C3 (mg/dL)

96.42 ± 20.62

 − 73.7

 − 163.1

15.8

0.106

C4 (mg/dL)

19.68 ± 8.40

 − 77.7

 − 297.9

142.5

0.488

TSH (mU/L)

2.16 ± 4.70

29.0

 − 360.5

418.5

0.884

Free T4 (ng/dL)

1.07 ± 0.26

 − 2422.4

 − 9503.0

4658.2

0.502

Sugar AC (mg/dL)

106.81 ± 35.66

 − 14.1

 − 65.8

37.7

0.593

Glycohemoglobin (%)

6.07 ± 1.33

 − 447.7

 − 1838.8

943.5

0.527

Insulin (mIU/L)

11.33 ± 12.31

 − 103.3

 − 252.6

46.1

0.175

Insulin/Sugar

0.38 ± 2.21

 − 222.5

 − 1128.2

683.2

0.629

HOMA-IR

2.68 ± 3.19

 − 243.9

 − 868.3

380.4

0.442

Apo A1 (g/L)

1.37 ± 0.30

 − 4431.4

 − 10,512.7

1649.8

0.153

Uric Acid (mg/dL)

5.97 ± 1.79

 − 695.8

 − 1730.0

338.5

0.187

HDL (mg/dL)

48.70 ± 16.27

15.9

 − 97.3

129.2

0.782

VLDL (mg/dL)

20.67 ± 13.88

 − 40.1

 − 175.2

95.0

0.560

LDL (mg/dL)

97.35 ± 30.80

 − 30.7

 − 91.3

29.8

0.319

Cholesterol (mg/dL)

165.81 ± 36.85

 − 26.5

 − 76.8

23.8

0.302

Triglyceride (mg/dL)

104.20 ± 63.69

 − 8.5

 − 37.7

20.6

0.565

Ferritin (ng/mL)

274.01 ± 445.64

1.0

 − 3.2

5.1

0.651

Ceruloplasmin (mg/dL)

24.79 ± 5.43

15.1

 − 327.7

358.0

0.931

Iron (ug/dL)

119.29 ± 55.86

24.9

 − 8.1

57.8

0.139

TIBC (ug/dL)

326.69 ± 56.80

 − 13.2

 − 45.7

19.3

0.424

UIBC (ug/dL)

200.22 ± 84.92

 − 14.3

 − 42.0

13.3

0.309

  1. “HBV positivity” include (a) HBV without HCV, n = 219; and (b) HBV, HCV co-infection, n = 18
  2. “HCV positivity” include (a) HCV without HBV, n = 110; and (b) HBV, HCV co-infection, n = 18